Search research articles
Contact Us
Filters
Showing results (71-80 of 410) with videos related to
Page
of 41
Sort By:
Optics Express
|
May 29, 2009
7x 40 Gb/s base-rate RZ all-optical broadcasting utilizing an electroabsorption modulator
L Xu, N Chi, K Yvind, et al.
Journal of Tropical Medicine
|
January 1, 2025
High-Throughput Shotgun Metagenomics of Microbial Footprints Uncovers a Cocktail of Noxious Antibiotic Resistance Genes in the Winam Gulf of Lake Victoria, Kenya
Sandra Khatiebi, Kelvin Kiprotich, Zedekiah Onyando, et al.
Cancer
|
December 7, 2018
Medical resource utilization of abiraterone acetate plus prednisone added to androgen deprivation therapy in metastatic castration-naive prostate cancer: Results from LATITUDE
Tracy Li, Conrado Franco-Villalobos, Irina Proskorovsky, et al.
Pediatric Blood & Cancer
|
March 2, 2019
Cutaneous reactions to targeted therapies in children with CNS tumors: A cross-sectional study
Hannah Song, Connie S Zhong, Mark W Kieran, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 16, 2013
Clinical activity of abiraterone acetate in patients with metastatic castration-resistant prostate cancer progressing after enzalutamide
K L Noonan, S North, R L Bitting, et al.
American Journal of Clinical Oncology
|
October 24, 2002
Carboplatin and vinblastine for the treatment of metastatic transitional cell carcinoma of the urothelial tract
Huda A Al-Karim, Kennard E Tan, Kim N Chi, et al.
Plos One
|
November 28, 2012
Tolerance of protein folding to a circular permutation in a PDZ domain
Greta Hultqvist, Avinash S Punekar, Angela Morrone, et al.
European Urology
|
June 30, 2009
Castration-resistant prostate cancer: from new pathophysiology to new treatment targets
Kim N Chi, Anders Bjartell, David Dearnaley, et al.
International Journal of Molecular Sciences
|
April 12, 2013
Plasma miRNAs as biomarkers to identify patients with castration-resistant metastatic prostate cancer
Akira Watahiki, Robyn J Macfarlane, Martin E Gleave, et al.
Oncotarget
|
November 28, 2014
PD-L1 is highly expressed in Enzalutamide resistant prostate cancer
Jennifer L Bishop, Alexander Sio, Arkhjamil Angeles, et al.
Page
of 41
Search research articles
Search
Showing results (71-80 of 410) with videos related to
Sort By:
Page
of 41
Optics Express
|
May 29, 2009
7x 40 Gb/s base-rate RZ all-optical broadcasting utilizing an electroabsorption modulator
L Xu, N Chi, K Yvind, et al.
Journal of Tropical Medicine
|
January 1, 2025
High-Throughput Shotgun Metagenomics of Microbial Footprints Uncovers a Cocktail of Noxious Antibiotic Resistance Genes in the Winam Gulf of Lake Victoria, Kenya
Sandra Khatiebi, Kelvin Kiprotich, Zedekiah Onyando, et al.
Cancer
|
December 7, 2018
Medical resource utilization of abiraterone acetate plus prednisone added to androgen deprivation therapy in metastatic castration-naive prostate cancer: Results from LATITUDE
Tracy Li, Conrado Franco-Villalobos, Irina Proskorovsky, et al.
Pediatric Blood & Cancer
|
March 2, 2019
Cutaneous reactions to targeted therapies in children with CNS tumors: A cross-sectional study
Hannah Song, Connie S Zhong, Mark W Kieran, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 16, 2013
Clinical activity of abiraterone acetate in patients with metastatic castration-resistant prostate cancer progressing after enzalutamide
K L Noonan, S North, R L Bitting, et al.
American Journal of Clinical Oncology
|
October 24, 2002
Carboplatin and vinblastine for the treatment of metastatic transitional cell carcinoma of the urothelial tract
Huda A Al-Karim, Kennard E Tan, Kim N Chi, et al.
Plos One
|
November 28, 2012
Tolerance of protein folding to a circular permutation in a PDZ domain
Greta Hultqvist, Avinash S Punekar, Angela Morrone, et al.
European Urology
|
June 30, 2009
Castration-resistant prostate cancer: from new pathophysiology to new treatment targets
Kim N Chi, Anders Bjartell, David Dearnaley, et al.
International Journal of Molecular Sciences
|
April 12, 2013
Plasma miRNAs as biomarkers to identify patients with castration-resistant metastatic prostate cancer
Akira Watahiki, Robyn J Macfarlane, Martin E Gleave, et al.
Oncotarget
|
November 28, 2014
PD-L1 is highly expressed in Enzalutamide resistant prostate cancer
Jennifer L Bishop, Alexander Sio, Arkhjamil Angeles, et al.
Page
of 41